2023 Approvals

FDA Approves VEOPOZ on August 18th 2023: A New Treatment for CHAPLE Disease

FDA Approves VEOPOZ on August 18th 2023: A New Treatment for CHAPLE Disease

What is VEOPOZ prescribed for?   VEOPOZ is prescribed to treat patients 1 year old and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. What is the name of the drug and what does it do? The drug, VEOPOZ, pronounced VEE-oh-poz, (generic name: pozelimab-bbfg)is an innovative treatment recently approved by the FDA to...

FDA Approves ORSERDU for Advanced Breast Cancer on January 27, 2023

FDA Approves ORSERDU for Advanced Breast Cancer on January 27, 2023

What is ORSERDU prescribed for?   For treatment of postmenopausal women or adult men, with ERpositive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy What is the name of the drug and what does it do?  ORSERDU (generic name: elacestrant), pronounced...

FDA Approves Sohonos for Fibrodysplasia Ossificans Progressiva on August 16, 2023

FDA Approves Sohonos for Fibrodysplasia Ossificans Progressiva on August 16, 2023

What is Sohonos prescribed for?   Sohonos is prescribed to reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva. What is the name of the drug and what does it do? Sohonos, pronounced so-ho-nos, (generic name:...

FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

What is Elrexfio prescribed for?   Elrexfio is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Elrexfio, pronounced el-reks-fe-o, (generic name: elranatamab-bcmm). It is a prescription medication approved for...

FDA Approves Talvey for Multiple Myeloma on August 9, 2023

FDA Approves Talvey for Multiple Myeloma on August 9, 2023

What is Talvey prescribed for?   Talvey is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Talvey, pronounced tal vay, (generic name: talquetamab-tgvs). It is a prescription medication approved to treat adults...